DV
Dividend Vision

NNNN — Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares (NNNN)

Total return is 51.5% over the past 1.5 years, 22.7 points ahead of SPY at 28.8%. Its deepest 1-year drawdown was 82.5%.

NNNN is an equity fund that provides exposure to Anbio Biotechnology Class A Ordinary Shares. As a newly launched fund with an inception date of February 19, 2025, it focuses on biotechnology sector equities rather than dividend income generation. The fund does not currently report a distribution rate or yield profile, making it primarily suitable for investors seeking capital appreciation in the biotechnology space rather than those focused on regular income.

NNNN key facts

Asset type
Stock
Asset class
Equity
Inception date
02/19/2025
Last close
$8.74
Market cap
$417,844,256
Average volume
72700.0
Payout ratio
0.0
P/E ratio
63.4667
Forward P/E
0.0
EPS
$0.15